(5-methyl-6-oxo-1,6-dihydro-pyridin-3-yl)-1,2-dideoxy-ribofuranose-5-monophosphate
Star0
Identification
- Generic Name
- (5-methyl-6-oxo-1,6-dihydro-pyridin-3-yl)-1,2-dideoxy-ribofuranose-5-monophosphate
- DrugBank Accession Number
- DB04060
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 305.221
Monoisotopic: 305.066438383 - Chemical Formula
- C11H16NO7P
- Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as c-glycosyl compounds. These are glycoside in which a sugar group is bonded through one carbon to another group via a C-glycosidic bond.
- Kingdom
- Organic compounds
- Super Class
- Organic oxygen compounds
- Class
- Organooxygen compounds
- Sub Class
- Carbohydrates and carbohydrate conjugates
- Direct Parent
- C-glycosyl compounds
- Alternative Parents
- Pyridinones / Monoalkyl phosphates / Methylpyridines / Dihydropyridines / Oxolanes / Heteroaromatic compounds / Secondary alcohols / Lactams / Oxacyclic compounds / Dialkyl ethers show 5 more
- Substituents
- Alcohol / Alkyl phosphate / Aromatic heteromonocyclic compound / Azacycle / C-glycosyl compound / Dialkyl ether / Dihydropyridine / Ether / Heteroaromatic compound / Hydrocarbon derivative show 16 more
- Molecular Framework
- Aromatic heteromonocyclic compounds
- External Descriptors
- ribitol phosphate, C-glycosylpyridine (CHEBI:44126)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- Not Available
- InChI Key
- MUWYCJQCZPFLFI-IVZWLZJFSA-N
- InChI
- InChI=1S/C11H16NO7P/c1-6-2-7(4-12-11(6)14)9-3-8(13)10(19-9)5-18-20(15,16)17/h2,4,8-10,13H,3,5H2,1H3,(H,12,14)(H2,15,16,17)/t8-,9+,10+/m0/s1
- IUPAC Name
- {[(2R,3S,5R)-3-hydroxy-5-(5-methyl-6-oxo-1,6-dihydropyridin-3-yl)oxolan-2-yl]methoxy}phosphonic acid
- SMILES
- CC1=CC(=CNC1=O)[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1
References
- General References
- Not Available
- External Links
- PubChem Compound
- 17754095
- PubChem Substance
- 46506947
- ChemSpider
- 16744120
- ZINC
- ZINC000012504117
- PDBe Ligand
- MTR
- PDB Entries
- 1ngt
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP -1.4 Chemaxon pKa (Strongest Acidic) 1.24 Chemaxon pKa (Strongest Basic) -2.6 Chemaxon Physiological Charge -2 Chemaxon Hydrogen Acceptor Count 6 Chemaxon Hydrogen Donor Count 4 Chemaxon Polar Surface Area 125.32 Å2 Chemaxon Rotatable Bond Count 4 Chemaxon Refractivity 68.57 m3·mol-1 Chemaxon Polarizability 27.65 Å3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.8464 Blood Brain Barrier + 0.8344 Caco-2 permeable - 0.7099 P-glycoprotein substrate Non-substrate 0.6485 P-glycoprotein inhibitor I Non-inhibitor 0.8685 P-glycoprotein inhibitor II Non-inhibitor 0.9824 Renal organic cation transporter Non-inhibitor 0.9357 CYP450 2C9 substrate Non-substrate 0.7777 CYP450 2D6 substrate Non-substrate 0.8031 CYP450 3A4 substrate Substrate 0.5185 CYP450 1A2 substrate Non-inhibitor 0.748 CYP450 2C9 inhibitor Non-inhibitor 0.8478 CYP450 2D6 inhibitor Non-inhibitor 0.8996 CYP450 2C19 inhibitor Non-inhibitor 0.7915 CYP450 3A4 inhibitor Non-inhibitor 0.8404 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.8721 Ames test Non AMES toxic 0.6505 Carcinogenicity Non-carcinogens 0.8539 Biodegradation Not ready biodegradable 0.9006 Rat acute toxicity 2.4414 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9694 hERG inhibition (predictor II) Non-inhibitor 0.8703
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS splash10-006t-6910000000-b8f3d8c6d2c3a076eb36 Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-0a4i-1692000000-cf079c6944ec1fe1fe5d Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-0udi-2009000000-5b574642714bff422c5f Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-0a5i-0920000000-588c20c28617b063366a Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-004i-9000000000-748238b1c3b922cce79f Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-004i-9100000000-9f1aab53a08a88098a70 Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-01p9-0910000000-37f4713fd4ecde1cf47d Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 160.34412 predictedDeepCCS 1.0 (2019) [M+H]+ 162.73973 predictedDeepCCS 1.0 (2019) [M+Na]+ 168.75058 predictedDeepCCS 1.0 (2019)
Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52